MED – Medifast Inc.
MED — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
15.65
Margin Of Safety %
-36
Put/Call OI Ratio
0.15
EPS Next Q Diff
0.1
EPS Last/This Y
-0.15
EPS This/Next Y
1.25
Price
12.61
Target Price
12
Analyst Recom
3
Performance Q
-0.55
Upside
-746.2%
Beta
0.74
Ticker: MED
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | MED | 11.01 | 0.09 | 0.03 | 25803 |
| 2026-07-14 | MED | 10.59 | 0.09 | 0.04 | 25835 |
| 2026-07-15 | MED | 10.66 | 0.09 | 0.08 | 25848 |
| 2026-07-16 | MED | 10.49 | 0.09 | 1.13 | 25859 |
| 2026-07-17 | MED | 10.26 | 0.09 | 0.00 | 25859 |
| 2026-07-20 | MED | 10.38 | 0.11 | 0.91 | 20525 |
| 2026-07-21 | MED | 10.53 | 0.12 | 0.04 | 20852 |
| 2026-07-22 | MED | 9.76 | 0.11 | 0.01 | 21022 |
| 2026-07-23 | MED | 9.44 | 0.11 | 0.06 | 22337 |
| 2026-07-24 | MED | 9.68 | 0.11 | 0.41 | 22476 |
| 2026-07-27 | MED | 9.9 | 0.11 | 0.00 | 22499 |
| 2026-07-28 | MED | 9.78 | 0.11 | 1.18 | 22486 |
| 2026-07-29 | MED | 9.64 | 0.12 | 0.00 | 22941 |
| 2026-07-30 | MED | 9.91 | 0.12 | 0.02 | 22941 |
| 2026-07-31 | MED | 9.86 | 0.12 | 0.77 | 22992 |
| 2026-08-03 | MED | 9.74 | 0.12 | 0.06 | 23021 |
| 2026-08-04 | MED | 13.08 | 0.12 | 0.38 | 23781 |
| 2026-08-05 | MED | 12.23 | 0.13 | 0.45 | 25257 |
| 2026-08-06 | MED | 12.17 | 0.14 | 0.53 | 26195 |
| 2026-08-07 | MED | 12.66 | 0.15 | 0.15 | 26906 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | MED | 11.06 | -100.0 | - | -1.85 |
| 2026-07-14 | MED | 10.61 | -100.0 | - | -1.85 |
| 2026-07-15 | MED | 10.62 | -100.0 | - | -1.85 |
| 2026-07-16 | MED | 10.47 | -100.0 | - | -1.85 |
| 2026-07-17 | MED | 10.24 | -100.0 | - | -1.85 |
| 2026-07-20 | MED | 10.37 | -100.0 | - | -1.85 |
| 2026-07-21 | MED | 10.52 | -100.0 | - | -1.85 |
| 2026-07-22 | MED | 9.77 | -100.0 | - | -1.85 |
| 2026-07-23 | MED | 9.43 | -100.0 | - | -1.85 |
| 2026-07-24 | MED | 9.69 | -100.0 | - | -1.85 |
| 2026-07-27 | MED | 9.88 | -100.0 | - | -1.85 |
| 2026-07-28 | MED | 9.77 | -100.0 | - | -1.85 |
| 2026-07-29 | MED | 9.65 | -100.0 | - | -1.85 |
| 2026-07-30 | MED | 9.91 | -100.0 | - | -1.85 |
| 2026-07-31 | MED | 9.86 | -100.0 | - | -1.85 |
| 2026-08-03 | MED | 9.71 | -100.0 | - | -1.85 |
| 2026-08-04 | MED | 9.71 | -100.0 | - | -1.85 |
| 2026-08-05 | MED | 12.28 | -100.0 | - | -1.85 |
| 2026-08-06 | MED | 12.11 | -100.0 | - | -1.85 |
| 2026-08-07 | MED | 12.61 | -100.0 | - | -1.85 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | MED | 3.38 | 0.78 | 14.97 |
| 2026-07-14 | MED | 3.38 | 0.78 | 14.97 |
| 2026-07-15 | MED | 3.38 | 0.78 | 14.97 |
| 2026-07-16 | MED | 3.38 | 0.78 | 14.97 |
| 2026-07-17 | MED | 3.38 | 0.78 | 14.97 |
| 2026-07-20 | MED | 3.38 | 2.19 | 14.97 |
| 2026-07-21 | MED | 3.38 | 2.19 | 14.97 |
| 2026-07-22 | MED | 3.38 | 2.19 | 14.97 |
| 2026-07-23 | MED | 3.38 | 2.19 | 14.97 |
| 2026-07-24 | MED | 3.38 | 2.19 | 14.97 |
| 2026-07-27 | MED | 3.38 | 2.29 | 15.72 |
| 2026-07-28 | MED | 3.38 | 2.29 | 15.72 |
| 2026-07-29 | MED | 3.38 | 2.29 | 15.72 |
| 2026-07-30 | MED | 3.38 | 2.29 | 15.72 |
| 2026-07-31 | MED | 3.38 | 2.29 | 15.72 |
| 2026-08-03 | MED | 3.38 | -3.95 | 15.72 |
| 2026-08-04 | MED | 3.38 | -3.95 | 15.72 |
| 2026-08-05 | MED | 3.38 | -3.95 | 15.72 |
| 2026-08-06 | MED | 3.37 | -3.95 | 15.72 |
| 2026-08-07 | MED | 3.37 | -3.95 | 15.65 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.28
Avg. EPS Est. Current Quarter
-0.62
Avg. EPS Est. Next Quarter
-0.18
Insider Transactions
3.37
Institutional Transactions
-3.95
Beta
0.74
Average Sales Estimate Current Quarter
67
Average Sales Estimate Next Quarter
63
Fair Value
8.04
Quality Score
42
Growth Score
26
Sentiment Score
91
Actual DrawDown %
95.2
Max Drawdown 5-Year %
-95.9
Target Price
12
P/E
Forward P/E
PEG
P/S
0.45
P/B
0.72
P/Free Cash Flow
35.19
EPS
-2.33
Average EPS Est. Cur. Y
-1.85
EPS Next Y. (Est.)
-0.6
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-8.08
Relative Volume
0.61
Return on Equity vs Sector %
-35.3
Return on Equity vs Industry %
-61.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
MED
Consumer Cyclical
$12.62
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
65.2
Range 1M
84.2%
Sup Dist
7.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-91.7%
EPS NY
75.7%
52W%
65.9%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-23.7% upside
Upside
-23.7%
Quality
42
MoS
-36%
MED — P/E HistoricalPersonal Services
MEDIFAST INCSector: Consumer Cyclical
Industry: Personal Services
Employees: 380
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
MED
Latest News
—
Caricamento notizie per MED…
stock quote shares MED – Medifast Inc. Stock Price stock today
news today MED – Medifast Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MED – Medifast Inc. yahoo finance google finance
stock history MED – Medifast Inc. invest stock market
stock prices MED premarket after hours
ticker MED fair value insiders trading